Chem. J. Chinese Universities ›› 2003, Vol. 24 ›› Issue (8): 1360.

• Articles • Previous Articles     Next Articles

Synthesis and Properties of Tetrabromo-2,3-naphthalocyanine Lead(Ⅱ)

HE Chun-Ying1, WU Yi-Qun1, SONG Ying-Lin2, WANG Yu-Xiao2, ZUO Xia1   

  1. 1. College of Chemistry and Chemical Technology, Heilongjiang University, Harbin 150080, China;
    2. Department of Physics, Harbin Institute of Technology, Harbin 150001, China
  • Received:2002-09-11 Online:2003-08-24 Published:2003-08-24

Abstract: Tetrabromo-2,3-naphthalocyanine lead(PbNcBr4) was synthesized in the presence of 1, 8-diazabicycloundec-7-ene(DBU) and its electronic absorption spectra, thermal stability, optical limiting property and the effect of bromine substituent on the above properties were investigated.There is one strong Q-absorption band in nearinfrared region.Bromine substituent attached to outer Nc ring results in the Q-band of PbNcBr4shifting to the blue compared to the complex unsubstituted.The polarity of solvents have influences on the electronic absorption spectra greatly< The complex shows high thermal stabilities and appears to be more stable in N2(the onset temperature 504.6 ℃) than in O2(the onset temperature 326.8 ℃).The thermal stabilities decrease on account of bromine substituent attached to outer Nc ring and declining extent changes with the varieties of atmosphere(decreased by 175℃ in N2, 25 ℃ in O2).Decomposition mechanisms differ according to the varieties of atmosphere with one step in O2and multi steps in N2.At a relatively high linear transmittance of 88%, the limiting threshold is 148mJ/cm2, the clamped fluence is 332 mJ/cm2, and the damage fluence is about 3J/cm2. The optical limiting behavior of PbNcBr4is better than that of C60whose limiting threshold is above 240 mJ/cm2with a linear transmittance of 70%. It can be regarded as a new kind of materials which has a better optical limiting property.

Key words: Tetrabromo-2,3-naphthalocyanine lead, Thermal stability, Optical limiting property

CLC Number: 

TrendMD: